Physician profile
Xiaodan Wang
NPI 1134381163
$935.81
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2020: $15.81 · 2022: $187 · 2023: $103 · 2024: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $377.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $182.12 | 2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $158.31 | 2019-2023 | |
| Mylan Specialty L.P. | $118.07 | 2019-2024 | Yupelri |
| Astellas Pharma US INC | $108.64 | 2019 | |
| Inari Medical, INC. | $101.09 | 2022 | |
| Janssen Pharmaceuticals, INC | $64.32 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $61.99 | 2023-2024 | Eliquis |
| Pfizer INC. | $61.32 | 2019 | |
| Allergan, INC. | $35.21 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $28.93 | 2024 | Uptravi, Opsumit |
| Novo Nordisk INC | $15.81 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiaodan Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.